JOINT FILING AGREEMENT
EXHIBIT A
The undersigned hereby agree that the Statement on Schedule 13D with respect to the common
shares of Helix BioPharma Corp., dated as of October 3, 2011, is, and any further amendments
thereto (including amendments on Schedule 13D or Schedule 13G) signed by each of the undersigned
shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the
provisions of Rule 13d-1(k) under the United States Securities Exchange Act of 1934 and further
agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence
thereof, the undersigned, being duly authorized, have executed this
joint filing agreement this 3rd day of October, 2011.
| ACM ALPHA CONSULTING MANAGEMENT AG | ||||||
| By: | /s/ Xxxxxxxx Xxxxxxxxx | |||||
| Name: Xxxxxxxx Xxxxxxxxx | ||||||
| Title: President and Chief Executive Officer | ||||||
| ACM ALPHA CONSULTING MANAGEMENT EST. | ||||||
| By: | /s/ Xxxxxxx Xxxxxxxxx | |||||
| Name: Xxxxxxx Xxxxxxxxx | ||||||
| Title: President and Managing Director | ||||||
| XXXXXXXX XXXXXX | ||||||
| /s/ Xxxxxxxx Xxxxxx | ||||||
| XXXXXXXX XXXXXXXXX | ||||||
| /s/ Xxxxxxxx Xxxxxxxxx | ||||||
| XXXXXXX XXXXXXXXX | ||||||
| /s/ Xxxxxxx Xxxxxxxxx | ||||||
